Dishman Pharmaceuticals & Chemicals | DISHMAN | NSE - Pharmaceuticals


Performance Valuation Growth Insiders Summary Balance Sheet Income Statement Cash Flow Quarterly
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..

Upgrade Membership to see 10 year accurate financial statements.
 Chart
2015
2016
2017
2018
Net Income
Net Income
1,592
2,334
2,161
2,308
Cash flow Operating Act...
Cash flow Operating Activities
2,9372,7863,0272,264
Investments in PPE
Investments in PPE
-1,424-1,239-1,480-2,165
Cash flow Investing Act...
Net cash used for Investment Activities
-1,581-1,529-1,424-2,972
Dividend Paid
Dividend Paid
1133231940
Cash flow Financing Act...
Net cash provided by Financing Activities
-1,420-941-1,371776
Cash at beginning of period
Cash at beginning of period
308244348586
Cash at end of period
Cash at end of period
244560586655
Free Cash Flow
Free Cash Flow
1,513
1,548
1,547
100